Evaluating and Treating Sexual Addiction Commentary by GRAY N
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Medications to Treat Opioid Use Disorder Research Report
Research Report Revised Junio 2018 Medications to Treat Opioid Use Disorder Research Report Table of Contents Medications to Treat Opioid Use Disorder Research Report Overview How do medications to treat opioid use disorder work? How effective are medications to treat opioid use disorder? What are misconceptions about maintenance treatment? What is the treatment need versus the diversion risk for opioid use disorder treatment? What is the impact of medication for opioid use disorder treatment on HIV/HCV outcomes? How is opioid use disorder treated in the criminal justice system? Is medication to treat opioid use disorder available in the military? What treatment is available for pregnant mothers and their babies? How much does opioid treatment cost? Is naloxone accessible? References Page 1 Medications to Treat Opioid Use Disorder Research Report Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone. Overview An estimated 1.4 million people in the United States had a substance use disorder related to prescription opioids in 2019.1 However, only a fraction of people with prescription opioid use disorders receive tailored treatment (22 percent in 2019).1 Overdose deaths involving prescription opioids more than quadrupled from 1999 through 2016 followed by significant declines reported in both 2018 and 2019.2,3 Besides overdose, consequences of the opioid crisis include a rising incidence of infants born dependent on opioids because their mothers used these substances during pregnancy4,5 and increased spread of infectious diseases, including HIV and hepatitis C (HCV), as was seen in 2015 in southern Indiana.6 Effective prevention and treatment strategies exist for opioid misuse and use disorder but are highly underutilized across the United States. -
Todd Bowman, Ph.D., LPC
Todd Bowman, Ph.D., LPC Home: 21938 W. 176th St. Work: Counselor Education Department Olathe, KS 66062 Indiana Wesleyan University (913) 956-9374 4201 S. Washington St Email: [email protected] Marion, IN 46953 Education/Training 6/03-7/08 Doctor of Philosophy, Counseling Psychology, School of Applied Health and Educational Psychology Oklahoma State University, Stillwater, OK Counseling Psychology Ph.D. Program (APA Accredited) Completion: 7/2008; Conferral: 12/2008 8/99-5/03 Bachelor of Arts, School of Natural and Social Sciences Mount Vernon Nazarene University Major in Psychology, Minor in Spanish Graduation: 5/2003 1/18-present Certified Sexual Addiction Therapist- Candidate (CSAT) International Inventory for Trauma and Addiction Professionals Academic Experience 8/14-present Associate Professor, Counselor Education Department, Indiana Wesleyan University, CACREP Accredited Courses taught include: Research for Counselors, Individual Appraisal, Theories and Techniques of Helping Relationships. Psychopathology, Theory and Techniques in Group Counseling, Issues in Addiction Recovery Supervisor: Mark Gerig, Ph.D. Responsibilities: planning for all phases of teaching in the course including lecture development, learning management software platform building (Learning Studio), and grading. Courses were taught in online format with approximately 12-16 students in each course. 8/08-6/14 Associate Professor, Program Director- Sexual Addiction Treatment Provider (SATP) Certificate Program, Counselor Education Department, MidAmerica Nazarene University, CACREP Accreditation 7/10 Courses developed and taught include: (Master’s program): Foundations of Mental Health, Theories of Counseling, Psychodiagnosis and Todd Bowman 2 Treatment, Prevention and Intervention in Mental Health, Theories of Group Counseling, Individual and Family Assessment, Career Development/Career Counseling, Counselor as Consultant, Research in Counseling, Practicum/Internship. -
Understanding Addiction, Helping Clients and Colleagues
ALABAMA LAWYER ASSISTANCE PROGRAM Understanding Addiction, Helping Clients and Colleagues By Jeanne Marie Leslie rugs change the brain–they according to the American Bar change its structure and how it Association, is 15 to 18 percent.3 D works.1 Many of these changes Lawyers rank high in the incidences of are responsible for the behaviors we see depression compared to other professions in individuals addicted to drugs. and a disproportionate number of Neuroscience has made significant lawyers commit suicide;4 in Alabama advances in our ability to identify and there are about a dozen lawyer suicides understand the mechanisms involved in every year. And these are only the ones the addicted brain. These advancements about which we know. Many lawyers, clearly confirm what many in the addic- including some you know, may be strug- tion medicine field have known for some gling with an addiction or mental health time: the obsession and compulsion to problem when help is readily available use drugs in the addicted brain is instinc- through ALAP. tual and paramount to survival.2 Ignorance and stigma have contributed Addiction Facts to the confusion, moral judgments and Dr. Nora D. Volkow, director of the poor understanding of this destructive National Institute of Drug Abuse and often fatal disease. Our courts are (NIDA), explains how the neuro-chemi- overwhelmed by the behaviors, criminal cal mechanisms of drug abuse catalyze and civil, associated with addiction. and accelerate the onset addiction: Therefore, understanding addiction is “Recognizing drug addiction as a chron- essential for lawyers. Lawyers are in ic, relapsing disease characterized by com- unique positions to initiate change, to pulsive drug seeking and use is critical to advocate for medical treatment over tra- being able to identify and help those who ditional sanctions and to refer individuals have it. -
ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
The ASAM NATIONAL The ASAM National Practice Guideline 2020 Focused Update Guideline 2020 Focused National Practice The ASAM PRACTICE GUIDELINE For the Treatment of Opioid Use Disorder 2020 Focused Update Adopted by the ASAM Board of Directors December 18, 2019. © Copyright 2020. American Society of Addiction Medicine, Inc. All rights reserved. Permission to make digital or hard copies of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for commercial, advertising or promotional purposes, and that copies bear this notice and the full citation on the fi rst page. Republication, systematic reproduction, posting in electronic form on servers, redistribution to lists, or other uses of this material, require prior specifi c written permission or license from the Society. American Society of Addiction Medicine 11400 Rockville Pike, Suite 200 Rockville, MD 20852 Phone: (301) 656-3920 Fax (301) 656-3815 E-mail: [email protected] www.asam.org CLINICAL PRACTICE GUIDELINE The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update 2020 Focused Update Guideline Committee members Kyle Kampman, MD, Chair (alpha order): Daniel Langleben, MD Chinazo Cunningham, MD, MS, FASAM Ben Nordstrom, MD, PhD Mark J. Edlund, MD, PhD David Oslin, MD Marc Fishman, MD, DFASAM George Woody, MD Adam J. Gordon, MD, MPH, FACP, DFASAM Tricia Wright, MD, MS Hendre´e E. Jones, PhD Stephen Wyatt, DO Kyle M. Kampman, MD, FASAM, Chair 2015 ASAM Quality Improvement Council (alpha order): Daniel Langleben, MD John Femino, MD, FASAM Marjorie Meyer, MD Margaret Jarvis, MD, FASAM, Chair Sandra Springer, MD, FASAM Margaret Kotz, DO, FASAM George Woody, MD Sandrine Pirard, MD, MPH, PhD Tricia E. -
Nonparaphilic Sexual Addiction Mark Kahabka
The Linacre Quarterly Volume 63 | Number 4 Article 2 11-1-1996 Nonparaphilic Sexual Addiction Mark Kahabka Follow this and additional works at: http://epublications.marquette.edu/lnq Part of the Ethics and Political Philosophy Commons, and the Medicine and Health Sciences Commons Recommended Citation Kahabka, Mark (1996) "Nonparaphilic Sexual Addiction," The Linacre Quarterly: Vol. 63: No. 4, Article 2. Available at: http://epublications.marquette.edu/lnq/vol63/iss4/2 Nonparaphilic Sexual Addiction by Mr. Mark Kahabka The author is a recent graduate from the Master's program in Pastoral Counseling at Saint Paul University in Ottawa, Ontario, Canada. Impulse control disorders of a sexual nature have probably plagued humankind from its beginnings. Sometimes classified today as "sexual addiction" or "nonparaphilic sexual addiction,"l it has been labeled by at least one professional working within the field as "'The World's Oldest/Newest Perplexity."'2 Newest, because for the most part, the only available data until recently has come from those working within the criminal justice system and as Patrick Carnes points out, "they never see the many addicts who have not been arrested."3 By definition, both paraphilic4 and nonparaphilic sexual disorders "involve intense sexual urges and fantasies" and which the "individual repeatedly acts on these urges or is highly distressed by them .. "5 Such disorders were at one time categorized under the classification of neurotic obsessions and compulsions, and thus were usually labeled as disorders of an obsessive compulsive nature. Since those falling into this latter category, however, perceive such obessions and compulsions as "an unwanted invasion of consciousness"6 (in contrast to sexual impulse control disorders, which are "inherently pleasurable and consciously desired"7) they are now placed under the "impulse control disorder" category.s To help clarify the distinction: The purpose of the compulsions is to reduce anxiety, which often stems from unwanted but intrusive thoughts. -
Sexual Addiction and ADHD
P1: FCI/Sanjeev TJ1113-03 SAC.cls May 24, 2004 10:13 Sexual Addiction & Compulsivity, 11:7–20, 2004 Copyright © Taylor & Francis, Inc. ISSN: 1072-0162 print / 1532-5318 online DOI: 10.1080/10720160490458184 Sexual Addiction and ADHD: Is There A Connection? RICHARD BLANKENSHIP Director of North Atlanta Center for Christian Counseling, and Vice President of American Association of Certified Christian Sexual Addiction Specialists, Bethesda Workshops, Atlanta, Georgia, USA MARK LAASER Director of Faithful and True Ministries, Bethesda Workshops, and President of American Association of Certified Christian Sexual Addiction Specialists, Eden Prairie, Minnesota, USA Sexual addiction does not exist in isolation. As with most addictions, there can be co-occurring disorders. This study was conducted to investigate whether or not there is a connection between sexual ad- diction and attention deficit hyperactivity disorder (ADHD). This article will discuss the results of the study as well as the limitations of the instruments used. The importance of trauma model treatment with sexual addiction and ADHD will be considered. The need for further research will also be addressed. The term ADHD will be used throughout the article except where specific quotes use other termi- nology. The DSM-IV uses the term Attention Deficit/Hyperactivity Disorder and identifies a combined type, a predominantly inatten- tive type and a predominantly hyperactive type. “Jim” is a man in his 22nd year of marriage. During this time he has acted out sexually with a number of affair partners. Jim has a family history of sub- stance abuse and addiction. When he was arrested for sexually acting out in public he sought treatment for his sexual addiction. -
Amphetamines Help People Struggling with Amphetamine Addiction
Reducing Harm & Finding Help, Continued detox facilities, and addiction treatment programs can help with withdrawal. Amphetamine addiction can be treated in a residential setting (often called “rehab”) or in an outpatient setting (when the patient lives at home, but goes to treatment appointments 1-7 times per week). Effective types of counseling for benzodiazepine addiction include cognitive behavioral therapy, motivational interviewing, and twelve- step facilitation. There are also recovery support groups and online forums that can Amphetamines help people struggling with amphetamine addiction. Narcotics Anonymous, Alcoholics Anonymous, and groups like SMART Recovery or LifeRing are all available to support people with Information about amphetamine addiction. Recovery apps specific to amphetamine addiction can be downloaded to your smart phone that Your Health provide lists of recovery support meetings, reading material, tools like sobriety counters, and more. © 2016 Institute for Research, Education and Training in Addictions Amphetamines – Amphetamines & who inject amphetamines and/or share equipment can develop injection site What Are They? My Health, Continued infections, damage to their veins, Hepatitis B & C, HIV, and blood clots. Amphetamines are a category of drug that decisions. For some people, amphetamine include prescription medications (like intoxication can create or worsen mental Adderall), methamphetamine (often illness symptoms like anxiety, paranoia, and shortened to “meth”), and MDMA (often hallucinations. called “ecstasy” or “Molly”). Although these drugs are not identical, they are all included Unknown drugs: Because some amphetamines in the category of amphetamines. are illegal, they carry additional risks. Users of methamphetamine and MDMA cannot be Amphetamines are stimulants. They can sure of the drug’s contents or dose. -
Molecular Mechanisms of Addiction
Molecular Mechanisms of Addiction Eric J. Nestler Nash Family Professor The Friedman Brain Institute Medical Model of Addiction • Pathophysiology - To identify changes that drugs produce in a vulnerable brain to cause addiction. • Individual Risk - To identify specific genes and non-genetic factors that determine an individual’s risk for (or resistance to) addiction. - About 50% of the risk for addiction is genetic. Only through an improved understanding of the biology of addiction will it be possible to develop better treatments and eventually cures and preventive measures. Scope of Drug Addiction • 25% of the U.S. population has a diagnosis of drug abuse or addiction. • 50% of U.S. high school graduates have tried an illegal drug; use of alcohol and tobacco is more common. • >$400 billion incurred annually in the U.S. by addiction: - Loss of life and productivity - Medical consequences (e.g., AIDS, lung cancer, cirrhosis) - Crime and law enforcement Diverse Chemical Substances Cause Addiction • Opiates (morphine, heroin, oxycontin, vicodin) • Cocaine • Amphetamine and like drugs (methamphetamine, methylphenidate) • MDMA (ecstasy) • PCP (phencyclidine or angel dust; also ketamine) • Marijuana (cannabinoids) • Tobacco (nicotine) • Alcohol (ethanol) • Sedative/hypnotics (barbiturates, benzodiazepines) Chemical Structures of Some Drugs of Abuse Cocaine Morphine Ethanol Nicotine ∆9-tetrahydrocannabinol Drugs of Abuse Use of % of US population as weekly users 100 25 50 75 0 Definition of Drug Addiction • Loss of control over drug use. • Compulsive drug seeking and drug taking despite horrendous adverse consequences. • Increased risk for relapse despite years of abstinence. Definition of Drug Addiction • Tolerance – reduced drug effect after repeated use. • Sensitization – increased drug effect after repeated use. -
The Addictive Potential of Sexual Behavior (Impulse) Review2
Page 1 of 9 Impulse: The Premier Journal for Undergraduate Publications in the Neurosciences Submitted for Publication January, 2018 The Addictive Potential of Sexual Behavior Heather Bool D’Youville College, Buffalo, New York This paper examines the addictive potential of sexual behavior through behavioral and neurophysiological mechanisms analogous to other formalized addictions. Sexual behavior refers to any action or thought preformed with the intention of sexual gratification, such as the consumption of explicit material, masturbation, fantasizing of sexual scenarios, and sexual intercourse. Addiction is defined by the presence of tolerance, preoccupation, withdrawal, dependence, and the continuation of behavior despite risk and/or harm. Sexual addiction demonstrates high relapse potential due to the frequency of reward-associated cues encountered in daily life, and the low effort and risk required for sexual pleasure. Currently, sexual addiction lacks a formal diagnosis despite behavioral, psychological, and physiological evidence. An official diagnosis recognized by a governing authority, such as the American Psychological Association, would offer greater access to treatment, funding for research, and exposure and education for the general public about this disorder. Abbreviations: None Keywords: Sexual Behavior; Addiction; Sexual Addiction; Neurophysiology; Behavioral Neuroscience Introduction “Sexual addiction” is an umbrella term Confusion remains regarding the for sexual impulsivity, sexual compulsivity, out- etiology and nosology of sexual addiction, of-control sexual behavior, hypersexual which has led to the lack of a universally behavior or disorder, sexually excessive accepted criterion and, more importantly, the behavior or disorder, Don Jaunism, satyriasis, absence of a formal diagnosis. A lack of and obsessive-compulsive sexual behavior operationalization of the disorder has severe (Beech et al., 2009; Karila et al., 2014; effects on research; due to the use of Rosenberg et al., 2014). -
Everything You Wanted to Know but May Have Been Afraid to Ask
Wellness Tip Sheet Maryland State Bar Association’s Lawyer Assistance Program Everything you wanted to know but may have been afraid to ask What is Sexual Addiction? According to Dr. Founder of the International Institute for Trauma and Addiction Professionals (IITAP), sexual addiction is defined as any sexually related compulsive behavior which interferes with normal living and causes severe stress on family, friends, loved ones, or one’s work environment. Sexual addiction is sometimes referred to as sexual dependency or sexual compulsivity. By any name it is a compulsive behavior that completely dominates the addict’s life. Sexual addicts make sex a priority, making it more important than family, friends and work. Sex becomes the organizing principle of addicts’ lives. They are willing to sacrifice what they cherish most in order to preserve and continue their unhealthy behavior. Background Information: • It is estimated that 3 to 6% of the US population suffer from sexual addiction. That’s about 17 to 37 million people • Although it has traditionally been considered a middle aged male dominant addiction, females now represent more than 20% of the affected population. • Sex addiction does not discriminate. It crosses all educational, socioeconomic, racial and sexual-orientation lines, but one commonality among addicts is a sense of shame. • There has been progress in the medical field which includes sexual addiction being diagnosed as a disorder and having treatment options available. • In the past ten years treatment options have gone from fewer than 100 therapists to over 1,500, with treatment centers specializing in sexual addiction. What Causes Sexual Addiction? Sexual addiction, just like any addiction, is very complex. -
Hypersexuality Or Sexual Addiction?
Hypersexuality or sexual addiction? Professor Kevan Wylie MD FRCP FRCPsych FRCOG FECSM FRSPH Consultant in Sexual Medicine Porterbrook Clinic NHS & Urology NHS, SHEFFIELD. UK. Honorary Professor of Sexual Medicine & Psychiatry, University of SHEFFIELD. UK. Visiting Professor, SHEFFIELD Hallam University, UK. Visiting Professor, University of LIVERPOOL, UK. Visiting Professor, YEREVAN State Medical University, Armenia. Adjunct Associate Professor, University of SYDNEY, Australia (2007-2014). President, World Association for Sexual Health (2012-2017). Hypersexuality or sexual addiction? INTRODUCTION 2 [email protected] Problematic Hypersexuality (PH) (Kingston & Firestone, 2008) PH is a clinical syndrome characterised by loss of control over sexual fantasies, urges and behaviours, which are accompanied by adverse consequences and/or personal distress (Gold & Heffner 1998; Kafka 2001) Controversial and elusive concept to define and measure (Rinehart & McCabe 1997) Some agreement on the essential features of PH Impaired control Continuation of behaviour despite consequences (Marshall & Marshall 2006; Rinehart & McCabe 1997) Types of Hypersexuality Behaviour (Kaplan & Krueger, 2010) Behavioural specifiers for hypersexuality Masturbation Pornography consumption Sexual behaviour with consenting adults Cybersex Telephone sex Strip club visits Hypersexual Behaviour (Kaplan & Krueger, 2010; Garcia & Thibaut, 2010) Men and women (much less frequently circa 5:1) with excessive sexual appetites Different terms to describe such behaviour; -
Randomized Controlled Trial of Dexamphetamine Maintenance for the Treatment of Methamphetamine
RESEARCH REPORT doi:10.1111/j.1360-0443.2009.02717.x Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependenceadd_2717 146..154 Marie Longo1, Wendy Wickes1, Matthew Smout1, Sonia Harrison1, Sharon Cahill1 & Jason M. White1,2 Pharmacotherapies Research Unit, Drug and Alcohol Services South Australia, Norwood, South Australia, Australia1 and Discipline of Pharmacology, University of Adelaide, Adelaide, South Australia, Australia2 ABSTRACT Aim To investigate the safety and efficacy of once-daily supervised oral administration of sustained-release dexam- phetamine in people dependent on methamphetamine. Design Randomized, double-blind, placebo-controlled trial. Participants Forty-nine methamphetamine-dependent drug users from Drug and Alcohol Services South Australia (DASSA) clinics. Intervention Participants were assigned randomly to receive up to 110 mg/day sustained- release dexamphetamine (n = 23) or placebo (n = 26) for a maximum of 12 weeks, with gradual reduction of the study medication over an additional 4 weeks. Medication was taken daily under pharmacist supervision. Measurements Primary outcome measures included treatment retention, measures of methamphetamine consump- tion (self-report and hair analysis), degree of methamphetamine dependence and severity of methamphetamine withdrawal. Hair samples were analysed for methamphetamine using liquid chromatography-mass spectrometry. Findings Treatment retention was significantly different between groups, with those who received dexamphetamine remaining in treatment for an average of 86.3 days compared with 48.6 days for those receiving placebo (P = 0.014). There were significant reductions in self-reported methamphetamine use between baseline and follow-up within each group (P < 0.0001), with a trend to a greater reduction among the dexamphetamine group (P = 0.086).